Modulation of the Tumor Microenvironment with Trastuzumab Enables Radiosensitization in HER2+ Breast Cancer

Modulation of the Tumor Microenvironment with Trastuzumab Enables Radiosensitization in HER2+ Breast Cancer

DNA damage repair and tumor hypoxia contribute to intratumoral cellular and molecular heterogeneity and affect radiation response. The goal of this study is to investigate anti-HER2-induced radiosensitization of the tumor microenvironment to enhance fractionated radiotherapy in models of HER2+ breas...

Full description

Bibliographic Details
Main Authors: Patrick N. Song, Ameer Mansur, Yun Lu, Deborah Della Manna, Andrew Burns, Sharon Samuel, Katherine Heinzman, Suzanne E. Lapi, Eddy S. Yang, Anna G. Sorace
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
PDX
BT474
MDA-MB-361
BCM 3472
trastuzumab
[<sup>18</sup>F]-FMISO
Online Access:https://www.mdpi.com/2072-6694/14/4/1015

Internet

https://www.mdpi.com/2072-6694/14/4/1015

Similar Items